Form 4: Hims & Hers CLO Soleil Boughton Reports Equity Transactions

Hims & Hers Health, Inc.'s Chief Legal Officer, Soleil Boughton, reported the vesting and tax-related disposition of Class A Common Stock and Restricted Stock Units.

Summary

• Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., reported transactions involving Class A Common Stock and Restricted Stock Units (RSUs) on March 13, 2026.
• A total of 168,750 shares of Class A Common Stock were disposed of at $24.77 per share to cover tax withholding obligations related to the vesting and settlement of performance RSUs.
• 41,421 shares of Class A Common Stock were acquired through the conversion of vested RSUs.
• These RSU conversions stemmed from multiple grants with service-based vesting requirements over four-year periods, with quarterly installments starting from June 15, 2022, June 15, 2023, June 15, 2024, and June 15, 2025.
• Following these transactions, Soleil Boughton beneficially owns 313,643 shares of Class A Common Stock directly.
• Remaining unvested derivative securities (RSUs) include 48,892, 96,792, and 74,194 units from various grants.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral. It reports routine executive compensation events (RSU vesting and tax-related share dispositions) that are standard practice and do not indicate any material change in the company's operational or financial performance.

Positives

• The vesting of Restricted Stock Units (RSUs) represents compensation earned by the Chief Legal Officer, indicating continued retention and alignment of interests with shareholders.
• The value of shares withheld for taxes, $24.77 per share, provides a recent valuation point for the company's stock.

Negatives

• The disposition of 168,750 shares to cover tax obligations, while standard for RSU vesting, represents a reduction in the officer's direct shareholding.

Future Outlook

The filing details future vesting schedules for remaining Restricted Stock Units, indicating ongoing equity compensation for the Chief Legal Officer. These RSUs are subject to service-based vesting over a 4-year period, with quarterly installments on specified dates.

Industry Context

StockSavvy.ai notes that routine Form 4 filings, such as this one detailing RSU vesting and tax-related dispositions, are common occurrences for executives in publicly traded companies. These transactions reflect standard equity compensation practices aimed at aligning executive incentives with long-term shareholder value. The reported share price of $24.77 for tax dispositions provides a market-based valuation at the time of the transaction, which can be compared to peer companies in the telehealth and consumer health sectors like Teladoc Health (TDOC) or GoodRx (GDRX) to gauge relative executive compensation value.

Comparison to Industry Standards

• The practice of granting Restricted Stock Units (RSUs) with service-based vesting over a multi-year period (e.g., 4 years) is a standard compensation mechanism across various industries, including technology and healthcare, similar to practices at companies like Amazon or Microsoft.
• The automatic withholding of shares to cover tax obligations upon RSU vesting is a common and efficient method for managing executive equity compensation, widely adopted by most public companies to simplify tax compliance for both the company and the executive.
• The reported share price of $24.77 for the tax disposition is specific to Hims & Hers Health, Inc. and would need to be compared against the stock performance of direct competitors such as Teladoc Health (TDOC) or Amwell (AMWL) on the transaction date to assess relative valuation and compensation effectiveness.

Related Party Transactions

• The transactions involve the Chief Legal Officer of Hims & Hers Health, Inc. and the issuer itself, which are considered related parties in the context of executive compensation and equity transactions.

Stakeholder Impact

• Shareholders: The vesting and tax-related dispositions are routine and reflect standard executive compensation, aligning management incentives with shareholder value over time. The disposition for taxes slightly increases the public float but is generally not material.
• Employees: The filing highlights the company's use of equity compensation, which can be a positive signal for employee retention and motivation, particularly for key executives.

Next Steps

• Continued vesting of remaining Restricted Stock Units for Soleil Boughton according to their respective service-based schedules, with quarterly installments on specified dates (March 15, June 15, September 15, and December 15).

Key Dates

Keywords

Hims & Hers Health, HIMS, Soleil Boughton, Chief Legal Officer, SEC Form 4, Insider Transaction, Restricted Stock Units, RSU Vesting, Equity Compensation, Tax Withholding, Class A Common Stock